CLINICAL TRIAL
Sitagliptin improves albuminuria in patients with type 2 diabetes mellitus Hiroko Mori, Yosuke Okada, Tadashi Arao, Yoshiya Tanaka* First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
Keywords Albuminuria, Dipeptidyl peptidase-4 inhibitor, Sitagliptin *Correspondence Yoshiya Tanaka Tel.: +81-93-603-1611 Fax: +81-93-691-9334 E-mail address: tanaka@ med.uoeh-u.ac.jp J Diabetes Invest 2014; 5: 313–319 doi: 10.1111/jdi.12142
ABSTRACT Introduction: The aim of the present study was to determine the effect of sitagliptin on microalbuminuria in patients with type 2 diabetes mellitus. Materials and Methods: A total of 85 patients with type 2 diabetes mellitus (age >20 years,
Sitagliptin improves albuminuria in patients with type 2 diabetes mellitus Hiroko Mori, Yosuke Okada, Tadashi Arao, Yoshiya Tanaka* First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
Keywords Albuminuria, Dipeptidyl peptidase-4 inhibitor, Sitagliptin *Correspondence Yoshiya Tanaka Tel.: +81-93-603-1611 Fax: +81-93-691-9334 E-mail address: tanaka@ med.uoeh-u.ac.jp J Diabetes Invest 2014; 5: 313–319 doi: 10.1111/jdi.12142
ABSTRACT Introduction: The aim of the present study was to determine the effect of sitagliptin on microalbuminuria in patients with type 2 diabetes mellitus. Materials and Methods: A total of 85 patients with type 2 diabetes mellitus (age >20 years,
